Top B, Mooi W J, Klaver S G, Boerrigter L, Wisman P, Elbers H R, Visser S, Rodenhuis S
Division of Experimental Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis, Amsterdam.
Int J Cancer. 1995 Apr 21;64(2):83-91. doi: 10.1002/ijc.2910640203.
A series of 54 resected primary non-small-cell lung carcinomas was analyzed for p53 gene mutations and for p53 protein accumulation and the findings were correlated with clinical parameters. Mutations in exons 5 through 8 of the p53 gene were identified by a denaturing gradient gel electrophoresis (DGGE) assay and cycle sequencing, whereas p53 protein accumulation was detected in paraffin-embedded tissue by immunostaining using 2 different murine monoclonal antibodies (MAbs) (BP53-12 and DO7). A p53 gene mutation and/or p53 protein accumulation was found in 37 of 54 tumors. Mis-sense mutations were closely associated with positive immunostaining, which was intense in 15 out of 17 cases with a mutation. In 10 tumors, obvious p53 accumulation was detected in the absence of mutations in exons 5 through 8. Conversely, only one of 8 p53 non-sense mutations led to detectable p53 accumulation. The most frequent single base changes were G --> T transversions and C --> T transitions. The presence of a p53 alteration was not related to age, tumor size, stage or histology. However, we found a significant inverse correlation between p53 alterations and the presence of a K-ras mutation. This was reflected in the overall postoperative survival data: patients with p53 alterations in their tumors tended to have a better prognosis than those without a p53 alteration; however, this difference was lost when cases with a K-ras mutation were omitted from the analysis.
对54例切除的原发性非小细胞肺癌进行了分析,检测p53基因突变和p53蛋白积聚情况,并将结果与临床参数进行关联。通过变性梯度凝胶电泳(DGGE)分析和循环测序鉴定p53基因第5至8外显子的突变,而使用两种不同的鼠单克隆抗体(MAb)(BP53-12和DO7)通过免疫染色在石蜡包埋组织中检测p53蛋白积聚。在54个肿瘤中的37个中发现了p53基因突变和/或p53蛋白积聚。错义突变与阳性免疫染色密切相关,在17例有突变的病例中,有15例免疫染色强烈。在10个肿瘤中,在第5至8外显子无突变的情况下检测到明显的p53积聚。相反,8个p53无义突变中只有1个导致可检测到的p53积聚。最常见的单碱基变化是G→T颠换和C→T转换。p53改变的存在与年龄、肿瘤大小、分期或组织学无关。然而,我们发现p53改变与K-ras突变的存在之间存在显著的负相关。这反映在总体术后生存数据中:肿瘤有p53改变的患者预后往往比没有p53改变的患者好;然而,当分析中排除有K-ras突变的病例时,这种差异就消失了。